We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+5.18%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$1.1B
AUM Growth
+$67.2M
Cap. Flow
-$19.8M
Cap. Flow %
-1.8%
Top 10 Hldgs %
22.09%
Holding
1,024
New
290
Increased
193
Reduced
145
Closed
315

Sector Composition

Rank Sector Weight
1 Technology 11.03%
2 Healthcare 8.26%
3 Communication Services 7.46%
4 Financials 6.59%
5 Real Estate 4.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FT
151
Franklin Universal Trust
FT
$201M
$1.91M 0.17%
+260,403
New +$1.84M
BURL icon
152
Burlington
BURL
$22.5B
$1.89M 0.17%
11,090
+6,967
+169% +$1.14M
XLNX
153
PUT
DELISTED
Xilinx Inc
XLNX
$1.89M 0.17%
+160
New +$18.7K
EQIX icon
154
Equinix
EQIX
$103B
$1.88M 0.17%
3,719
+20
+0.5% +$9.6K
VZ icon
155
Verizon
VZ
$198B
$1.87M 0.17%
32,701
+15,780
+93% +$909K
EPC icon
156
Edgewell Personal Care
EPC
$1.28B
$1.84M 0.17%
+68,443
New +$2.44M
CFG icon
157
Citizens Financial Group
CFG
$30.1B
$1.84M 0.17%
+52,066
New +$1.81M
WVE icon
158
CALL
Wave Life Sciences
WVE
$1.14B
$1.84M 0.17%
+705
New +$19.8K
AVTX icon
159
Avalo Therapeutics
AVTX
$1.03B
$1.84M 0.17%
117
JJT
160
CALL
DELISTED
iPath Series B Bloomberg Tin Subindex Total ReturnSM ETN
JJT
$1.82M 0.17%
+702
New +$35K
CHKP icon
161
CALL
Check Point Software Technologies
CHKP
$13.6B
$1.81M 0.17%
157
+57
+57% +$6.73K
NBIX icon
162
PUT
Neurocrine Biosciences
NBIX
$17.7B
$1.81M 0.16%
214
-6
-3% -$493
BABA icon
163
PUT
Alibaba
BABA
$276B
$1.8M 0.16%
+106
New +$18.3K
CVS icon
164
CVS Health
CVS
$137B
$1.79M 0.16%
32,917
-11,288
-26% -$608K
ADBE icon
165
Adobe
ADBE
$94.5B
$1.78M 0.16%
6,029
+3,045
+102% +$846K
VVR icon
166
Invesco Senior Income Trust
VVR
$456M
$1.76M 0.16%
+407,619
New +$1.74M
CASH icon
167
Pathward Financial
CASH
$1.82B
$1.76M 0.16%
62,651
+7,096
+13% +$181K
QEP
168
DELISTED
QEP RESOURCES, INC.
QEP
$1.72M 0.16%
238,241
-57,462
-19% -$419K
VNDA icon
169
Vanda Pharmaceuticals
VNDA
$314M
$1.71M 0.16%
120,998
+85,064
+237% +$1.35M
BIIB icon
170
Biogen
BIIB
$29.5B
$1.69M 0.15%
7,208
-7,679
-52% -$1.77M
BHVN
171
PUT
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$1.68M 0.15%
383
+328
+596% +$18.5K
CIEN icon
172
Ciena
CIEN
$53.4B
$1.67M 0.15%
40,697
-23,695
-37% -$912K
TMO icon
173
Thermo Fisher Scientific
TMO
$208B
$1.64M 0.15%
5,579
+541
+11% +$149K
JBGS
174
JBG SMITH
JBGS
$832M
$1.61M 0.15%
41,043
+880
+2% +$36.2K
DHC
175
Diversified Healthcare Trust
DHC
$2.28B
$1.61M 0.15%
+195,018
New +$1.62M

Similar funds

Boothbay Fund Management's Q2 2019 Portfolio in Review

As of Q2 2019, Boothbay Fund Management held 1,024 positions worth $1.1B, up 6.5% from $1.03B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Boothbay Fund Management's Q2 2019 filing shows 290 new, 193 increased, 145 reduced and 315 closed positions. Its largest new stake was GigCapital2, Inc.: 1,261,000 shares worth $12.6M. The largest sale was Altaba Inc, an estimated $12.2M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Healthcare and Communication Services.

  • Boothbay Fund Management's largest Q2 2019 buy was GigCapital2, Inc.: 1,261,000 shares worth $12.6M.
  • Boothbay Fund Management added most to Sprott Physical Gold and Silver Trust in Q2 2019, an estimated $14.5M increase.
  • Boothbay Fund Management's biggest Q2 2019 reduction was Altaba Inc, cutting an estimated $12.2M.
  • Boothbay Fund Management fully exited Travelport Worldwide Limited in Q2 2019, selling an estimated $7.6M.
  • Boothbay Fund Management's ten largest holdings make up 22% of its $1.1B portfolio in Q2 2019.
  • Boothbay Fund Management opened 290 new positions and closed 315 in Q2 2019.
  • Boothbay Fund Management's portfolio value rose 6.5% quarter-over-quarter to $1.1B.

Based on Boothbay Fund Management's 13F filing for Q2 2019, filed 14 Aug 2019.